(Press-News.org) CHICAGO – The 2025 AACR Award for Lifetime Achievement in Cancer Research will be presented to Rakesh K. Jain, PhD, Fellow of the AACR Academy, during the AACR Annual Meeting 2025, to be held April 25-30 at the McCormick Place Convention Center in Chicago, Illinois.
Jain is the director of the Edwin L. Steele Laboratories for Tumor Biology in the Department of Radiation Oncology at Massachusetts General Hospital and the Andrew Werk Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School. He is being recognized for his lifelong achievements and pioneering contributions that have transformed the scientific understanding of the tumor microenvironment and its role in cancer progression and treatment. Most notably, his groundbreaking hypothesis of vascular normalization reshaped the use of antiangiogenic therapy and led to FDA-approved drug combinations. Jain’s visionary integration of engineering and oncology has advanced drug delivery, immunotherapy, and cancer treatment strategies, while his celebrated mentorship and leadership have inspired countless scientists, clinicians, and physician-scientists.
The AACR Award for Lifetime Achievement in Cancer Research honors individuals who have made significant fundamental contributions to cancer research, either through a single scientific discovery or a body of work. These contributions, whether in research, leadership, or mentorship, must have had a lasting impact on the cancer field and must have demonstrated a lifetime commitment to progress against cancer.
For over four decades, Jain has championed the notion that solid tumors are complex organs and not simply a collection of cancerous cells. Underscoring this idea was his seminal discovery that abnormal blood and lymphatic vessels within tumors promote disease progression and restricts the delivery and efficacy of cancer therapeutics. Based on these findings, Jain boldly hypothesized that antiangiogenic drugs, originally designed to destroy blood vessels, could transiently remodel blood vessels to normal states and improve delivery and efficacy of chemo-, targeted-, and immune-therapeutics. Various preclinical experiments in his laboratory supported this hypothesis, and subsequent clinical trials led by Jain and his clinical collaborators confirmed that antiangiogenic agents improve the efficacy of various therapeutics, including immunotherapies, resulting in the FDA approval of several combinations involving antiangiogenic agents. Further, Jain designed a week-long intensive course on “Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology” to foster discussions among cancer researchers, physical scientists/engineers, and clinicians regarding the importance of the tumor microenvironment in tumor progression and treatment. Now in its 40th year, this course is ranked among the top courses offered by the Harvard Medical School Department of Continuing Medical Education.
“Through his interdisciplinary approach to research, Dr. Jain has fundamentally changed our scientific understanding of tumor biology, and thus has greatly advanced cancer research, improved treatments, and saved lives,” said Margaret Foti, PhD, MD (hc), chief executive officer of the AACR. “In addition, his dedication to championing the next generation of cancer researchers is an inspiration. The AACR is thrilled to celebrate and honor Dr. Jain with this richly deserved award.”
Jain has been a member of the AACR since 1979 and was elected as a Fellow of the AACR Academy in 2020. He was awarded the AACR-Princess Takamatsu Memorial Lectureship (2014). Jain has helped shape many of the AACR’s committees, association groups, and meetings. He has served as chair (2022-2023) and member (2014, 2011) of the AACR-Princess Takamatsu Memorial Lectureship Committee, member of the AACR-Women in Cancer Research Charlotte Friend Lectureship Committee (2018), and member of the AACR Gertrude B. Elion Young Investigator Award Committee (2010). He is a former member of the AACR Publications Committee (2018) and the AACR Clinical and Translational Cancer Research Grants Scientific Review Committee (2016). He has also served as chair of the AACR Special Conference on Engineering and Physical Sciences in Oncology Program Committee (2016), chair of the AACR Special Conference on Tumor Angiogenesis and Vascular Normalization: Bench to Bedside to Biomarkers Program Committee (2015), member of the AACR Special Conferences Committee (2012-2015), cochair of the AACR Frontiers in Basic Cancer Research Conference (2011-2012), chair of the AACR Symposium on Antiangiogenesis and Drug Delivery to Tumors (2005), and cochair of the AACR Annual Meeting Program Committee (2004).
His scientific accomplishments have been celebrated with numerous awards and honors throughout his career. In 2016, President Barack Obama presented Jain with the 2013 United States National Medal of Science in a White House ceremony. Other recent honors include the National Foundation for Cancer Research Szent-Györgyi Prize for Progress in Cancer Research (2023), the Proceedings of the National Academy of Sciences Cozzarelli Prize (2023), the North American Vascular Biology Organization Earl P. Benditt Award (2018), the American Association of Indian Scientists in Cancer Research Lifetime Achievement Award (2017), the Princess Takamatsu Cancer Research Fund International Lectureship (2016), the American Society of Clinical Oncology Science of Oncology Award and Lecture (2012), and the American Society for Investigative Pathology Rous-Whipple Award (2011).
In addition to being elected a Fellow of the AACR Academy, Jain was elected as a Fellow of the National Academy of Inventors (2017), the American Association for the Advancement of Science (2014), and the National Foundation for Cancer Research (2014). He was elected as a Foreign Fellow of the Indian National Science Academy (2015) and elected as a member of the National Academy of Sciences (2009), the American Academy of Arts and Sciences (2008), the National Academy of Engineering (2004), and the National Academy of Medicine (2003).
He earned his undergraduate degree at the Indian Institute of Technology in Kanpur, India, and his master’s and doctoral degrees at the University of Delaware, all with a focus on chemical engineering.
Jain’s award lecture will be held on Sunday, April 27, at 3 p.m. CT.
END
Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research
2025-04-03
ELSE PRESS RELEASES FROM THIS DATE:
Solar cells made of moon dust could power future space exploration
2025-04-03
The same dirt that clings to astronauts’ boots may one day keep their lights on. In a study publishing April 3 in the Cell Press journal Device, researchers created solar cells made out of simulated Moon dust. The cells convert sunlight into energy efficiently, withstand radiation damage, and mitigate the need for transporting heavy materials into space, offering a potential solution to one of space exploration's biggest challenges: reliable energy sources.
“The solar cells used in space now ...
Deporting immigrants may further shrink the health care workforce
2025-04-03
About The Study: More than 1 million noncitizen immigrants (one-third of them undocumented) work in health care in the U.S. Their ranks include skilled personnel who would be difficult to replace, especially if legal immigration is further restricted. Many health care workers may be removed if President Trump implements plans to deport undocumented immigrants and those losing temporary protected status (e.g., from Haiti and Venezuela).
Corresponding Author: To contact the corresponding author, Lenore S. Azaroff, MD, ScD, email Lenore_Azaroff@yahoo.com.
To ...
Border region emergency medical services in migrant emergency care
2025-04-03
About The Study: The findings of this qualitative study of emergency medical services (EMS) clinicians suggest that migration has a complex, multidimensional influence on EMS clinicians in the border region. Deterrence-focused actions have not decreased the number of crossings but rather pushed migrants to cross in more dangerous ways, leading to more injuries and deaths. The findings suggest that the strain placed on local EMS clinicians is unsustainable and may be exacerbated by increased deterrence-based policies. Instead, border-region EMS clinicians need increased federal funding to support their work.
Corresponding Author: To contact the corresponding ...
Resident physician intentions regarding unionization
2025-04-03
About The Study: In this survey study, most resident physicians reported either being in a union or supporting unionization at their institution, citing pay and financial security as critical factors in their consideration of unionization. Future research should investigate other factors and whether unionization achieves its goals of increased pay and benefits, work hours, and well-being.
Corresponding Author: To contact the corresponding author, Laura K. Barger, PhD, email lkbarger@hms.harvard.edu.
To access the embargoed study: Visit our For The Media ...
Healthy nutrition and physical lifestyle choices lower cancer mortality risk for survivors, new ACS study finds
2025-04-03
In 2022, the American Cancer Society (ACS) updated its nutrition and activity guidelines for cancer survivors, recommending they avoid obesity, stay physically active, eat a healthy diet, and limit alcohol intake. New research by ACS scientists shows a lifestyle aligned with these guidelines is associated with a lower mortality risk among non-smoking survivors of obesity-related cancers in the United States. Survivors who maintained a healthy lifestyle both before and after their diagnosis — or those who improved their habits after diagnosis — also had a lower mortality risk. The study is out today in the Journal of the National ...
Mass General Brigham researchers reveal 17 modifiable risk factors shared by stroke, dementia, and late-life depression
2025-04-03
Age-related brain diseases such as stroke, dementia, and late-life depression are a debilitating part of growing older, but people can lower their risk of these diseases through behavioral and lifestyle changes. In a new extensive systematic review, Mass General Brigham researchers identified 17 modifiable risk factors that are shared by stroke, dementia, and late-life depression. Modifying any one of them can reduce your risk of all three conditions. The findings, which provide evidence to inform novel tools, such as the Brain Care Score, are ...
Promising drug discovery research gets funding boost from Ontario Institute for Cancer Research
2025-04-03
April 3, 2025, ONTARIO – The Ontario Institute for Cancer Research (OICR) has announced its support for five Ontario research teams working to develop the next generation of medicines that kill tumours more effectively, cause fewer side effects and reduce the risk that cancer will come back.
The projects will be funded as part of OICR’s Cancer Therapeutics Innovation Pipeline (CTIP) awards, which provides research teams with up to $300,000 over two years to help advance promising drug discovery research so that new cancer drugs can more quickly and safely reach patients.
“Ontario ...
Carbon capture could become practical with scalable, affordable materials
2025-04-03
‘Vast majority’ of direct air capture research through air’s moisture swings relies on engineered ion exchange resins to sequester CO2
Other previously untested materials with dual functions like aluminum oxide and activated carbon would reduce associated energy and cost
Cheap, scalable carbon capture will be critical to reducing worldwide carbon footprint
EVANSTON, Ill. --- Researchers at Northwestern University have expanded the potential of carbon capture technology that plucks CO2 directly from the air by demonstrating that there are multiple ...
USC Norris Comprehensive Cancer Center opens state-of-the-art Newport Beach Radiation Oncology and Imaging Center
2025-04-03
Photos and b-roll package available for download here.
LOS ANGELES — USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened Keck Medicine of USC – Newport Beach Radiation Oncology and Imaging, a state-of-the-art radiation oncology and imaging center, at 4590 MacArthur Blvd. in Newport Beach.
The 12,500 square-foot clinical space houses new-to-market imaging and radiation therapy technology in a serene, beach-inspired space designed to help patients feel at ease.
“Our new radiation oncology and imaging center demonstrates our ongoing commitment to providing Orange County with world-class care,” said Rod ...
Chan Zuckerberg Biohub New York announces new investigators for immune system research to improve human health
2025-04-03
New York City, New York (April 3, 2025) – The Chan Zuckerberg Biohub New York (CZ Biohub NY) today announced nine new investigators to its growing roster of talented researchers. Joining from Columbia University, The Rockefeller University, and Yale University, the eight projects will focus on the Biohub’s mission to harness and bioengineer immune cells for the early detection, prevention, and treatment of a broad spectrum of age-related diseases, including neurodegenerative disorders and aggressive cancers. The funded projects support a variety of innovative strategies, including leveraging synthetic biology to address the limitations of current ...